Regor is a pioneering international biotech company with headquarters in Shanghai, China, and Boston, USA. Their current therapeutic areas of interest include oncology, metabolic diseases, and autoimmune diseases. Regor is committed to creating a highly efficient ecosystem for the accelerated discovery of innovative therapeutic agents with differentiated therapeutic values for patients around the world.

Pharmaceutical

Regor Therapeutics Group

Xiayang Qiu

Larissa

Lauren Xuan

Jinyang Hong

Mark Pirner

Julie Xie

Min Zhong

David J. Valacer

Xi Chen

Wenge Zhong

Xiaotian Zhu

The Research and Development team at Regor Therapeutics Group focuses on pioneering innovative therapeutic agents in oncology, metabolic, and autoimmune diseases. This multidisciplinary team, led by experts in endocrinology, pharmaceutical sciences, and clinical pharmacology, collaborates to accelerate drug discovery and development through cutting-edge research, bioinformatics, and preclinical studies, ensuring differentiated therapeutic solutions for patients globally.

Research and Development

Leadership Team

Operations and Management

Research and Development

About

Team members

Other teams at Regor Therapeutics Group

Leadership Team

Operations and Management